ABT · 10-Q · 2026Q2 · Full report

Capital Return Program

ABBOTT LABORATORIES · 2026-07-28 · Importance 77 · Surprise 82 · No source text

Abbott repurchased $1.225 billion of common shares during the first six months of 2026, purchasing 11.753 million shares compared with 0.185 million shares in the prior-year period. Treasury shares increased to 267.907 million at June 30, 2026 from 260.196 million at December 31, 2025. Abbott declared common dividends of $1.26 per share for the first six months, up 6.8% from $1.18 per share in 2025. Cash dividends paid increased 7.1% to $2.200 billion from $2.055 billion.

Key facts

• As of June 30, 2026, $5.6 billion remained available for repurchase under the share repurchase program authorized by the board in October 2024.
• Net cash from financing activities for the six months ended June 30, 2026: $13,795 million and for the six months ended June 30, 2025: $(3,152) million.
• In each of the first two quarters of 2026, Abbott declared a quarterly dividend of $0.63 per share, which represents an increase of 6.8 percent over the $0.59 per share dividend declared in each of the first two quarters of 2025.
• Abbott repurchased approximately 11.6 million common shares for $1.0 billion in the first six months of 2026.
• Dividends paid in the six months ended June 30, 2026: $2,200 million.
• Purchases of common shares in the six months ended June 30, 2026: $1,058 million (purchases recorded under treasury activity: $(1,058) shown for six months).
• Cash dividends declared per common share: three months 2026 $0.63 and six months 2026 $1.26 (per share amounts shown in statements).

Impact estimates